Health News

Jul 27, 2021 13:45 KST

SpeeDx Launch Solution for SARS-CoV-2 Variant Analysis

SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, have launched a new product line of research reagents to support reflex variant analysis for circulating SARS-CoV-2 variants

Jul 27, 2021 10:20 KST

Wyss Center Partners With Artiria Medical to Accelerate a Novel Therapy for Cerebral Vasospasm

The Wyss Center and Artiria Medical today announced a new partnership to accelerate the translation of a novel technology that has the potential to reduce deaths and improve quality of life for stroke

Jul 26, 2021 16:11 KST

Women in India are the first in the world to receive new heat-stable carbetocin formulation to prevent excessive bleeding after childbirth

After nearly a decade of public-private collaboration, Ferring Pharmaceuticals today announces the first use of heat-stable carbetocin (Carbetocin Ferring) for the prevention of excessive bleeding aft

Jul 26, 2021 09:43 KST

Merck Announces Appointment of Head of China & International for Healthcare

Merck, a leading science and technology company, today announced that Hong Chow will join its Healthcare business sector as Head of China & International on October 1. In this role at Merck, Chow will

Jul 23, 2021 15:00 KST

Humanigen’s Partner in South Korea Receives Ministry of Food and Drug Safety (MFDS) Approval to Conduct Phase 1 Study of Lenzilumab

Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), today announced its development and commercialization partners for South Korea and the Philippines, Telcon RF Pharmaceutical, Inc. (“Telcon”) and KPM Tech

Jul 23, 2021 13:30 KST

Invivoscribe Announces Key Submission in the EU, Expanded Presence and Activity in China

Invivoscribe, Inc., an industry pioneer in developing and commercializing diagnostic products and reagents for hematological malignancies, announced today a key submission in the EU, and expanded pres

Jul 23, 2021 11:50 KST

rf IDEAS to Showcase Collaboration with Healthcare Partners at HIMSS21

rf IDEAS, a leading manufacturer of credential readers for authentication and logical access, will showcase its latest identity access management solutions at HIMSS21, booth #2817. The focus of the

Jul 21, 2021 16:58 KST

Takeda Data at ISTH 2021 Highlight the Benefits of Prophylaxis for Patients with Rare Bleeding Disorders

Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (“Takeda”) today announced the results of a phase 3 trial investigating the efficacy and safety of recombinant von Willebrand factor (rVWF) p

Jul 21, 2021 10:55 KST

Crown Bioscience Invests in Commercial Leadership

Crown Bioscience, a JSR Life Sciences company, today announces the appointment of Alex Slater as Vice President of Business Development, North America and Europe. In this role, Mr Slater will be respo

Jul 20, 2021 11:40 KST

Takeda Announces the Submission of Its Corporate Governance Report to the Tokyo Stock Exchange

Takeda Pharmaceutical Company Limited (“Takeda”) (TOKYO:4502) (NYSE:TAK) today announced that it has filed its Corporate Governance Report with the Tokyo Stock Exchange (“TSE”) in accordance with the

Jul 20, 2021 10:25 KST

New Zealand Aviation Security Service to introduce UV light tray disinfection with Smiths Detection

Smiths Detection today announced with New Zealand Aviation Security Service (AvSec) that it has completed deployment of 18 units of its new Ultraviolet (UV) light tray disinfection kit to help enhance

Jul 19, 2021 10:30 KST

ViiV Healthcare presents data from second Dovato (dolutegravir/lamivudine) switch study confirming non-inferior efficacy and no virologic failure versus a broad range of regimens of at least 3 drugs

For media and investors only ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today presented

Jul 19, 2021 09:45 KST

Regencell Bioscience Holdings Limited Announces Pricing of Approximately $21.9 Million Initial Public Offering

Regencell Bioscience Holdings Limited (NASDAQ:RGC) (“Regencell” or the “Company”), an early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese

Jul 16, 2021 09:54 KST

SENSCO to Enter Global Market with Its Patented Thread Lifting ‘TIMEMACHINE LIFT ANCHORING DUAL COG’

SENSCO, a Korean professional medical device Thread Lift manufacturing company, said that its thread lifting, TIMEMACHINE LIFT ANCHORING DUAL COG is effective in improving skin elasticity and removing

Jul 15, 2021 10:20 KST

NEC’s Artificial Intelligence (AI) Supports Doctors to Determine If Colorectal Lesions Are Potentially Neoplastic

NEC Corporation (NEC; TOKYO: 6701) announced today the development of an AI technology for supporting doctors in determining if colorectal lesions are neoplastic or non-neoplastic. NEC developed a new

Jul 14, 2021 13:15 KST

iNova Pharmaceuticals Earns the Best Place To Work Global Certification

iNova Pharmaceuticals, a company that markets and distributes a wide range of over-the-counter and prescription medicines in Australasia, Asia and Africa, has recently been recognised as one of the be

Jul 13, 2021 09:45 KST

Theramex Appoints Sigurd Kirk to the Board of Directors

Theramex, a CVC Capital Partners (“CVC”) portfolio company focused on Women’s Health has announced that Sigurd (Sig) Kirk has been appointed as a member of the Board of Directors for Theramex. Therame

Jul 13, 2021 09:13 KST

AI in Diagnostic Imaging Market Registers Growth as Healthcare Sector Exhibits Demand for More Precise and Definitive Diagnosis: Fact MR Study

The Asia Pacific market for artificial intelligence (AI) in diagnostic imaging is likely to grow at an impressive pace through 2021. Fact MR, a leading market research and competitive intelligence pro

Jul 12, 2021 11:10 KST

Reversal of Aging of Human Cartilage, Restoring Youthfulness; the First of Its Kind Feat by Edogawa Hospital, Japan.

Cartilage of the knee joint, when severely damaged by age related wear and tear or injury or osteoarthritis, which is removed and usually discarded, during joint replacement surgery, now could be reju

Jul 12, 2021 09:45 KST

New Data from the Phase 3 HELP Study™ Open-Label Extension Evaluating Safety and Efficacy of TAKHZYRO® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced results from two final analyses from the Phase 3 HELP (Hereditary Angioedema Long-term Prophylaxis) Study™ Open-lab

Jul 09, 2021 10:20 KST

Kyalio Launches Day-to-Day Endo-Laparoscopic VR Surgical Library, the First in Asia

On July 1st, 2021, Kyalio and the Endoscopic and Laparoscopic Surgeons of Asia (ELSA), a leading surgical association with over 2,600 members, jointly launched the Day-to-Day Endo-Laparoscopic Virtual

Jul 08, 2021 11:40 KST

New Survey by Patient Safety Movement Foundation Reveals Only Forty-Five Percent of Patients Feel in Control of Their Health

The COVID-19 pandemic took the world by storm in 2020 and drew attention to healthcare performance, access and resource use. Unfortunately, it took the impact of something as monumental as a worldwide

Jul 07, 2021 14:00 KST

Alvotech Initiates Clinical Studies for AVT04, a Proposed Biosimilar to Stelara® (Ustekinumab)

Alvotech, the Iceland-based biosimilar company, today announced that the first patient has been dosed in the comparative, confirmatory efficacy and safety clinical study (AVT04-GL-301) for AVT04, Alvo

Jul 07, 2021 11:25 KST

Breakthrough results for empagliflozin confirm EMPEROR-Preserved as first and only successful trial for heart failure with preserved ejection fraction

The EMPEROR-Preserved Phase III trial met its primary endpoint, establishing empagliflozin as the first and only therapy to significantly reduce the risk of the composite of cardiovascular death or ho

Jul 07, 2021 10:30 KST

New Study Evaluates the Ability of Masimo SedLine® Brain Function Monitoring to Predict Neurological Outcomes and Long-term Survival in Post-Cardiac Arrest ICU Patients

Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of Critical Care in which Dr. Tae Youn Kim and colleagues at the Dongguk University College of Medicine and Yonse

News by Region

News by Industry